Literature DB >> 1718640

Separation of self from non-self in the complement system: a role for membrane cofactor protein and decay accelerating factor.

J P Atkinson1, T J Oglesby, D White, E A Adams, M K Liszewski.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 1718640      PMCID： PMC1554035          DOI： 10.1111/j.1365-2249.1991.tb06203.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  11 in total

Review 1.  Decay-accelerating factor and membrane cofactor protein.

Authors:  D M Lublin; J P Atkinson
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

Review 2.  Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster.

Authors:  M K Liszewski; T W Post; J P Atkinson
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

Review 3.  Evolutionary implications of a new bypass activation pathway of the complement system.

Authors:  T C Farries; K L Steuer; J P Atkinson
Journal:  Immunol Today       Date:  1990-03

4.  Decay accelerating factor regulates complement activation on glomerular epithelial cells.

Authors:  R J Quigg; A Nicholson-Weller; A V Cybulsky; J Badalamenti; D J Salant
Journal:  J Immunol       Date:  1989-02-01       Impact factor: 5.422

5.  Inhibition of complement by a substance isolated from human erythrocytes. II. Studies on the site and mechanism of action.

Authors:  E M Hoffmann
Journal:  Immunochemistry       Date:  1969-05

6.  Membrane cofactor protein of the complement system. A HindIII restriction fragment length polymorphism that correlates with the expression polymorphism.

Authors:  N S Bora; T W Post; J P Atkinson
Journal:  J Immunol       Date:  1991-04-15       Impact factor: 5.422

7.  Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitro.

Authors:  N K Cheung; E I Walter; W H Smith-Mensah; W D Ratnoff; M L Tykocinski; M E Medof
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

8.  Complement-mediated tumor cell damage induced by antibodies against membrane cofactor protein (MCP, CD46).

Authors:  T Seya; T Hara; M Matsumoto; Y Sugita; H Akedo
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

9.  Membrane cofactor protein of the complement system: alternative splicing of serine/threonine/proline-rich exons and cytoplasmic tails produces multiple isoforms that correlate with protein phenotype.

Authors:  T W Post; M K Liszewski; E M Adams; I Tedja; E A Miller; J P Atkinson
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

10.  Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b.

Authors:  T Seya; J R Turner; J P Atkinson
Journal:  J Exp Med       Date:  1986-04-01       Impact factor: 14.307
View more
  12 in total

Review 1.  Complement control protein factor H: the good, the bad, and the inadequate.

Authors:  Viviana P Ferreira; Michael K Pangburn; Claudio Cortés
Journal:  Mol Immunol       Date:  2010-08       Impact factor: 4.407

2.  Allelic variants of complement genes associated with dense deposit disease.

Authors:  Maria Asuncion Abrera-Abeleda; Carla Nishimura; Kathy Frees; Michael Jones; Tara Maga; Louis M Katz; Yuzhou Zhang; Richard J H Smith
Journal:  J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 10.121

Review 3.  Recent advances in the immunology of xenotransplantation.

Authors:  T Takahashi; S Saadi; J L Platt
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

Review 4.  Genetically-engineered pigs as sources for clinical red blood cell transfusion: What pathobiological barriers need to be overcome?

Authors:  Benjamin Smood; Hidetaka Hara; Leah J Schoel; David K C Cooper
Journal:  Blood Rev       Date:  2019-01-28       Impact factor: 8.250

Review 5.  The complex functioning of the complement system in xenotransplantation.

Authors:  Hongmin Zhou; Hidetaka Hara; David K C Cooper
Journal:  Xenotransplantation       Date:  2019-04-29       Impact factor: 3.907

6.  Xenotransplantation: Progress Along Paths Uncertain from Models to Application.

Authors:  Jeffrey L Platt; Marilia Cascalho; Jorge A Piedrahita
Journal:  ILAR J       Date:  2018-12-31

7.  Binding of factor H to tubular epithelial cells limits interstitial complement activation in ischemic injury.

Authors:  Brandon Renner; Viviana P Ferreira; Claudio Cortes; Ryan Goldberg; Danica Ljubanovic; Michael K Pangburn; Matthew C Pickering; Stephen Tomlinson; Amanda Holland-Neidermyer; Derek Strassheim; V Michael Holers; Joshua M Thurman
Journal:  Kidney Int       Date:  2011-05-04       Impact factor: 10.612

Review 8.  The role of genetically engineered pigs in xenotransplantation research.

Authors:  David K C Cooper; Burcin Ekser; Jagdeece Ramsoondar; Carol Phelps; David Ayares
Journal:  J Pathol       Date:  2015-10-07       Impact factor: 7.996

9.  Polyanion-induced self-association of complement factor H.

Authors:  Michael K Pangburn; Nenoo Rawal; Claudio Cortes; M Nurul Alam; Viviana P Ferreira; Mark A L Atkinson
Journal:  J Immunol       Date:  2009-01-15       Impact factor: 5.422

10.  Complement factor H and interleukin gene polymorphisms in patients with non-infectious intermediate and posterior uveitis.

Authors:  Ming-ming Yang; Timothy Y Y Lai; Pancy O S Tam; Sylvia W Y Chiang; Carmen K M Chan; Fiona O J Luk; Tsz-Kin Ng; Chi-Pui Pang
Journal:  Mol Vis       Date:  2012-07-11       Impact factor: 2.367
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.